cdmo.directory
← Compare landing

Genevoyager (Wuhan) Co., Ltd. vs Rentschler Biopharma SE

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGenevoyager (Wuhan) Co., Ltd.Rentschler Biopharma SE
SummaryLeading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.Rentschler Biopharma is a family-owned CDMO offering bioprocess development and manufacturing of biopharmaceuticals, with about 50 years of experience. It operates sites in Laupheim, Germany and Milford, Massachusetts, USA.
Services
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Translational Research
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Biologics Development & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Other)
Development capabilitiesData not yet provided.
  • Analytical method development
  • Formulation development
Manufacturing capabilitiesData not yet provided.Data not yet provided.
Locations
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
  • Headquarters, Laupheim, Baden-Württemberg, Germany
  • Milford, Milford, Massachusetts, USA
Certifications
  • China · Identifier: High-tech Enterprise (高新技术企业)
Data not yet provided.

Find similar companies

Genevoyager (Wuhan) Co., Ltd. alternatives · Rentschler Biopharma SE alternatives

Markdown mirror: /compare/genevoyager-2/rentschler-biopharma.md